{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "HBA2",
                "DNA Alteration": "c.427T>C",
                "GeneMutation": "p.*143Qext*31 Nonsense-LOF",
                "VariantAlleleFraction": "4.75%"
            },
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.1283C>T",
                "GeneMutation": "p.S428F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "8.73%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.380G>C",
                "GeneMutation": "p.R127P Nonsense-GOF",
                "VariantAlleleFraction": "3.1%"
            },
            {
                "Gene": "BRAF",
                "DNA Alteration": "c.1406G>T",
                "GeneMutation": "p.L597R Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "9.51%"
            },
            {
                "Gene": "HDAC1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Y303H Frameshift-LOF",
                "VariantAlleleFraction": "8.59%"
            },
            {
                "Gene": "PTEN",
                "DNA Alteration": "c.545T>G",
                "GeneMutation": "p.R130L Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.81%"
            },
            {
                "Gene": "XPC",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S346P Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "7.11%"
            },
            {
                "Gene": "APC",
                "DNA Alteration": "c.3920T>A",
                "GeneMutation": "p.I1307K Spliceregionvariant-GOF",
                "VariantAlleleFraction": "4.81%"
            },
            {
                "Gene": "PRKCA",
                "DNA Alteration": "c.1387G>C",
                "GeneMutation": "p.D463H Frameshift-LOF",
                "VariantAlleleFraction": "7.08%"
            },
            {
                "Gene": "AKT1",
                "DNA Alteration": "c.49G>A",
                "GeneMutation": "p.E17K Nonsense-GOF",
                "VariantAlleleFraction": "1.93%"
            },
            {
                "Gene": "HBA2",
                "DNA Alteration": "c.427T>C",
                "GeneMutation": "p.*143Qext*31 Spliceregionvariant-GOF",
                "VariantAlleleFraction": "3.18%"
            },
            {
                "Gene": "SDHB",
                "DNA Alteration": "c.487T>C",
                "GeneMutation": "p.S163P Stopgain-LOF",
                "VariantAlleleFraction": "8.88%"
            }
        ],
        "Germline": []
    }
}